We have recently shown that the levels of phosphorylated PKR (pPKR) were increased in the CSF of patients with AD and amnestic mild cognitive impairment (aMCI) compared to neurological disease controls, and that pPKR levels correlate with p-Tau 181 levels in AD patients [13]. Here, EIF2AK2 is linked to nervous system disorder.